...
首页> 外文期刊>Clinical & developmental immunology. >Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine
【24h】

Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine

机译:甲壳素,壳聚糖和糖化壳聚糖调节免疫反应:癌症疫苗的新型佐剂。

获取原文
           

摘要

With the development of cancer immunotherapy, cancer vaccine has become a novel modality for cancer treatment, and the important role of adjuvant has been realized recently. Chitin, chitosan, and their derivatives have shown their advantages as adjuvants for cancer vaccine. In this paper, the adjuvant properties of chitin and chitosan were discussed, and some detailed information about glycated chitosan and chitosan nanoparticles was also presented to illustrate the trend for future development.
机译:随着癌症免疫疗法的发展,癌症疫苗已经成为一种新型的癌症治疗手段,并且佐剂的重要作用近来已经得到认识。几丁质,壳聚糖及其衍生物已显示出作为癌症疫苗佐剂的优势。本文讨论了几丁质和壳聚糖的佐剂性质,并提供了一些有关糖化壳聚糖和壳聚糖纳米颗粒的详细信息,以说明未来的发展趋势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号